Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Return on Equity (2016 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Return on Equity for 9 consecutive years, with 0.58% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 251.0% year-over-year to 0.58%, compared with a TTM value of 0.58% through Dec 2025, up 251.0%, and an annual FY2025 reading of 0.86%, up 294.0% over the prior year.
  • Return on Equity was 0.58% for Q4 2025 at Zevra Therapeutics, up from 0.28% in the prior quarter.
  • Across five years, Return on Equity topped out at 6.5% in Q3 2022 and bottomed at 2.28% in Q1 2025.
  • Average Return on Equity over 5 years is 0.34%, with a median of 0.47% recorded in 2023.
  • The sharpest move saw Return on Equity surged 658bps in 2022, then crashed -689bps in 2023.
  • Year by year, Return on Equity stood at 0.07% in 2021, then tumbled by -842bps to 0.69% in 2022, then decreased by -17bps to 0.81% in 2023, then plummeted by -139bps to 1.93% in 2024, then surged by 130bps to 0.58% in 2025.
  • Business Quant data shows Return on Equity for ZVRA at 0.58% in Q4 2025, 0.28% in Q3 2025, and 0.03% in Q2 2025.